SMTL ID : 6do1.2 (1 other biounit)

Structure of nanobody-stabilized angiotensin II type 1 receptor bound to S1I8

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.90 Å

Oligo State

hetero-1-2-mer

Ligands

1 x SAR- ARG- VAL- TYR- ILE- HIS- PRO- ILE: Angiotensin-like peptide S1I8(Non-covalent)

SAR-ARG-VAL-TYR-ILE-HIS-PRO-ILE.1: 27 residues within 4Å: Chain A: I.21, Q.22, D.23, D.24, R.30, Y.42, W.91, Y.94, Y.99, V.115, S.116, L.119, R.174, V.186, C.187, A.188, F.189, H.190, Y.191, K.206, H.362, D.369, D.387, M.390, P.391, I.394, Y.398 28 PLIP interactions: 28 interactions with chain A Hydrophobic interactions: A:I.21, A:W.91, A:Y.99, A:V.115, A:L.119, A:V.186, A:A.188, A:Y.191, A:Y.191, A:I.394, A:Y.398 Hydrogen bonds: A:D.23, A:D.23, A:D.24, A:D.24, A:R.174, A:F.189, A:F.189, A:H.190, A:Y.191, A:Y.191, A:D.387 Water bridges: A:C.25, A:K.206 Salt bridges: A:K.206, A:H.362, A:D.369, A:D.387

1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.2: 2 residues within 4Å: Chain A: N.181, N.183 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:N.183

2 x CL: CHLORIDE ION(Non-functional Binders)

CL.3: 2 residues within 4Å: Chain A: R.417, Y.418 Ligand excluded by PLIP CL.4: 4 residues within 4Å: Chain A: G.412, K.413, K.414, F.415 Ligand excluded by PLIP

3 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)

OLC.5: 9 residues within 4Å: Chain A: S.43, F.46, V.47, P.89, A.92, V.93, A.96, M.97 Ligands: OLC.7 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:F.46, A:V.47, A:P.89, A:A.92, A:V.93 OLC.6: 5 residues within 4Å: Chain A: L.219, W.226, L.353, F.356, F.357 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:L.219, A:W.226, A:L.353, A:F.356, A:F.357 OLC.7: 7 residues within 4Å: Chain A: F.35, V.36, T.40, S.43, A.96, E.98 Ligands: OLC.5 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wingler, L.M. et al., Distinctive Activation Mechanism for Angiotensin Receptor Revealed by a Synthetic Nanobody. Cell (2019)

Release Date

2019-01-30

Peptides

Type-1 angiotensin II receptor,Soluble cytochrome b562 BRIL fusion protein: A
Nanobody Nb.AT110i1: BC

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

B
D

C
F

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Type-1 angiotensin II receptor,Soluble cytochrome b562 BRIL fusion protein

Nanobody Nb.AT110i1

Related Entries With Identical Sequence